Eye Diseases: all 747 studies
Page 2 of 8. Open to participants first (118), then studies with results posted, then the rest; newest registration first within each.
- Hydroxychloroquine in Mild Graves' OrbitopathyRecruitingNCT05126147Phase 4
- Multi-model Image of Doxycycline in TAORecruitingNCT05112211Not applicable
- Multi-model Image of Immunosuppressive Agents in TAORecruitingNCT05110040Not applicable
- Impact of COVID-19 on Quality of Life of Seniors With Eye Disease and Implementations to Improve WellnessRecruitingNCT04910282
- Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye DiseaseRecruitingNCT04673643Phase 2
- Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).RecruitingNCT04663750Phase 3
- Ocular Microbiome and Immune System in Dry EyesRecruitingNCT04658238
- Sirolimus for Graves' Orbitopathy (GO)Not yet recruitingNCT04598815Phase 2
- The Role of Transscleral Cyclophotocoagulation in Patients Undergoing a Boston KeratoprosthesisRecruitingNCT04232982Not applicable
- Identification and Measurement of Antioxidants and Cytokines in the Anterior Chamber of Various Ocular DisordersRecruitingNCT04101591
- Shanghai Children and Adolescent Diabetes Eye StudyRecruitingNCT03587948
- Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)RecruitingNCT03131726Phase 3
- A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' OrbitopathyNot yet recruitingNCT03098225Phase 4
- Stem Cell Ophthalmology Treatment Study IIRecruitingNCT03011541Not applicable
- Natural History, Pathogenesis, and Outcome of Ocular DisordersRecruitingNCT02821767
- IRIS Registry: Intelligent Research in Sight RegistryRecruitingNCT02485847
- Adaptive Optics Retinal ImagingRecruitingNCT02317328
- Screening for Research ParticipantsRecruitingNCT00655096
- Investigation of the Safety and Effectiveness of Monofocal Toric Intraocular Lens (IOL)CompletedNCT06399211Results posted
- A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye DiseaseCompletedNCT06226545Phase 2Results posted
- Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)CompletedNCT06011798Phase 2Results posted
- Fundus Findings and Thiol-Disulfide HomeostaisCompletedNCT05958927Results posted
- Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia SubjectsCompletedNCT05753189Phase 3Results posted
- Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of PresbyopiaCompletedNCT05728944Phase 3Results posted
- Nasal Spray Study in Sjogren's Dry Eye DiseaseCompletedNCT05700422Phase 4Results posted
- Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular EdemaCompletedNCT05697809Phase 2Results posted
- Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp ConfigurationsTerminatedNCT05686421Not applicableResults posted
- Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of PresbyopiaCompletedNCT05656027Phase 3Results posted
- Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of PresbyopiaCompletedNCT05431543Phase 2Results posted
- A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye DiseaseCompletedNCT05424549Phase 2Results posted
- A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye DiseaseCompletedNCT05403827Phase 3Results posted
- Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT05370495Phase 1/2Results posted
- Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of PresbyopiaCompletedNCT05294328Phase 2Results posted
- A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)CompletedNCT05276063Phase 2/3Results posted
- Study of ST-100 as Treatment for Dry Eye DiseaseCompletedNCT05241470Phase 2Results posted
- Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)TerminatedNCT05176717Phase 2/3Results posted
- Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)TerminatedNCT05158296Phase 2/3Results posted
- Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study)CompletedNCT05133180Phase 3Results posted
- The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseCompletedNCT05062330Phase 3Results posted
- A Clinical Trial to Assess Subjects With Dry Eye Disease.CompletedNCT04971031Phase 2Results posted
- Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.TerminatedNCT04799704Results posted
- OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)TerminatedNCT04757636Phase 3Results posted
- To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye DiseaseCompletedNCT04747977Phase 2Results posted
- Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye DiseaseCompletedNCT04734210Phase 2Results posted
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye DiseaseCompletedNCT04734197Phase 2Results posted
- Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationCompletedNCT04679935Phase 4Results posted
- The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseCompletedNCT04674358Phase 2/3Results posted
- A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye DiseaseCompletedNCT04583735Phase 4Results posted
- Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)CompletedNCT04567329Phase 3Results posted
- HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005TerminatedNCT04566445Phase 2Results posted
- Study of VVN001 Ophthalmic Solution in Dry Eye DiseaseCompletedNCT04556838Phase 2Results posted
- Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)CompletedNCT04535947Phase 2Results posted
- CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004CompletedNCT04523142Phase 3Results posted
- ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)CompletedNCT04523129Phase 3Results posted
- A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator ArmCompletedNCT04503551Phase 3Results posted
- A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye DiseaseCompletedNCT04498182Phase 2Results posted
- EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005TerminatedNCT04437368Phase 2Results posted
- ADVM-022 Intravitreal Gene Therapy for DMECompletedNCT04418427Phase 2Results posted
- Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye DiseaseCompletedNCT04393441Phase 3Results posted
- A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye DiseaseCompletedNCT04391894Phase 2Results posted
- Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.CompletedNCT04362670Phase 1/2Results posted
- Effect of Cequa™ in Subjects With Dry Eye DiseaseCompletedNCT04357795Phase 4Results posted
- Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT04201574Phase 1/2Results posted
- Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye DiseaseCompletedNCT04181593Phase 3Results posted
- Investigation of the Safety and Effectiveness of a Trifocal IOLCompletedNCT04176965Not applicableResults posted
- Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye DiseaseTerminatedNCT04159935Phase 4Results posted
- FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) TrialCompletedNCT04149210Phase 3Results posted
- 3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)CompletedNCT04144413Phase 3Results posted
- Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)CompletedNCT04140227Phase 3Results posted
- Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)CompletedNCT04139798Phase 3Results posted
- Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye DiseaseCompletedNCT04139122Phase 1/2Results posted
- Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens TypeCompletedNCT04105842Not applicableResults posted
- A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye DiseaseCompletedNCT04084483Phase 2Results posted
- Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye DiseaseCompletedNCT04036292Phase 3Results posted
- A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye DiseaseCompletedNCT04030962Phase 1/2Results posted
- Management of Signs and Symptoms Associated With Dry Eye DiseaseTerminatedNCT04015219Not applicableResults posted
- IVIG-eye Drops Treatment for Dry Eye DiseaseCompletedNCT03992482Phase 1/2Results posted
- Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter StudyCompletedNCT03956225Not applicableResults posted
- Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMDCompletedNCT03954626Phase 3Results posted
- ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )TerminatedNCT03938545Phase 2Results posted
- Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)CompletedNCT03922321Phase 2Results posted
- Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye DiseaseCompletedNCT03920215Phase 2/3Results posted
- A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye DiseaseCompletedNCT03916042Phase 2Results posted
- Extension Study to Study PQ-110-001 (NCT03140969)TerminatedNCT03913130Phase 1/2Results posted
- Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)CompletedNCT03889886Phase 2Results posted
- The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye DiseaseCompletedNCT03879863Phase 3Results posted
- Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)CompletedNCT03873246Phase 2Results posted
- FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMDTerminatedNCT03846193Phase 1/2Results posted
- Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye DiseaseTerminatedNCT03827564Not applicableResults posted
- Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)CompletedNCT03785340Phase 3Results posted
- Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland StimulationCompletedNCT03688802Phase 2Results posted
- Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic SubjectsCompletedNCT03660475Phase 2Results posted
- Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye DiseaseCompletedNCT03658811Not applicableResults posted
- A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)CompletedNCT03652051Phase 2Results posted
- Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye DiseaseCompletedNCT03636061Phase 2Results posted
- Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study)CompletedNCT03633461Phase 2Results posted
- A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye DiseaseCompletedNCT03598699Phase 2Results posted
- Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye DiseaseCompletedNCT03597139Phase 2Results posted
- Tofacitinib for Inflammatory Eye DiseaseStatus unknownNCT03580343Phase 2Results posted
- Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)CompletedNCT03452397Phase 2Results posted